BRIEF

on Zomedica Corp. (NASDAQ:ZOM)

Zomedica Receives CE Certification for VetGuardian® System, Expands in European Market

Stock price chart of Zomedica Corp. (EBR:ZOM) showing fluctuations.

Zomedica Corp, a veterinary health company, has announced its receipt of CE certification for the VetGuardian® system, paving the way for expansion across the European Union. This certification confirms that VetGuardian meets all EU health, safety, and environmental standards, which could greatly enhance veterinary care in the region.

The VetGuardian system utilizes innovative radar technology to monitor animal vital signs contactlessly, aiming to reduce stress during monitoring and increase clinical efficiency. According to Tony Blair, Chief Operating Officer, this certification not only broadens market potential but also equips veterinarians with advanced tools to improve patient and operational care.

This strategic advancement comes as the European veterinary market shows promising growth forecasts, with expectations to rise from $4 billion in 2022 to $5.4 billion by 2027. With the CE mark, Zomedica anticipates accelerated global expansion for its VetGuardian product, responding to widespread customer interest and increasing demand.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Zomedica Corp. news